Analytical Sciences

Delivering tailored analytical solutions.

Resolian’s highly skilled teams deliver tailored analytical solutions, whether it’s trace impurity analysis, pharmaceutical material characterization, or multidisciplinary approaches to support product development. Our dedicated scientists are here to empower your success by delivering precise, reliable, and customized analytical services.

Comprehensive Support: Resolian supports your projects from supplier evaluation to API characterization and batch release analysis, assisting you to ensure seamless development and manufacturing.

Innovative Methods: Our specialists can design and optimize novel test methods, applying validation, as required, to ensure data accuracy and regulatory compliance.

State-of-the-Art Facilities: Operating in cGMP-compliant laboratories with state-of-the-art equipment, Resolian upholds the highest standards of data quality and integrity.

Your Analytical Partner

Resolian is here to partner with you, offering expertise in:

  • Analytical Chemistry & Trace Analysis
  • Impurity Identification & Characterization
  • Extractables & Leachables
  • Elemental Impurities Analysis
  • Materials Characterization
  • Solid State Characterization
  • Chemistry, Manufacturing and Controls (CMC) Testing
  • Foreign Matter Analysis

Resolian is committed to delivering high-quality and efficient solutions tailored to your specific needs.

Reach out to us directly to learn more about Resolian’s Analytical Sciences services.

Our Analytical Sciences Services

Nitrosamines

Identifying and quantifying trace impurities in a diverse range of materials and marketed products.

Foreign Matter Analysis

Offering a comprehensive range of testing and consulting services.

Materials Characterization

Expertise in analyzing material properties crucial for drug development, supporting all stages with specialized testing and cGMP-compliant facilities.

Analytical Chemistry & Trace Analysis

Providing a comprehensive range of Analytical Chemistry services for diverse pharmaceutical applications.

Impurity Identification & Characterization

An interdisciplinary team offering precise and versatile Identification & Characterization services.

Extractables & Leachables

Expertise in E&L to support you from early stages of development through the full lifecycle of your product.

Elemental Impurities Analysis

Bespoke Elemental Impurities Analysis services to support you at every stage of product development and manufacture.
Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.